Contact
Please use this form to send email to PR contact of this press release:
ContraVir Pharmaceuticals Announces TXL™ Has Been Granted Orphan Drug Designation for the Treatment of HBV in a Pediatric Population
TO:
Please use this form to send email to PR contact of this press release:
ContraVir Pharmaceuticals Announces TXL™ Has Been Granted Orphan Drug Designation for the Treatment of HBV in a Pediatric Population
TO: